Back to search
Colorectal (Colon or Rectal) Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Colorectal (Colon or Rectal) Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Colorectal (Colon or Rectal) Cancer trials you may qualify forThe purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line tr…
This study aims to address the unmet medical need of participants with metastatic colorectal cancer (mCRC) who have previously been treated with irinotecan, oxa…
The purpose of this study is to assess the anti-tumor activity of amivantamab as a monotherapy (Cohorts A, B, and C), to assess the recommended phase 2 combinat…
The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-can…
The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant di…
The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy wi…
This was a multicenter, open-label extension study. Patients who received vismodegib (GDC-0449) in a Genentech-sponsored study and who had completed the parent…
This study is looking at how safe BHB810 is in adults with gastric and gastroesophageal adenocarcinoma (GEJ). The purpose of this study is also to look at: how…
This phase II trial studies how well low dose, reduced frequency nivolumab works in treating patients with cancer that cannot be removed by surgery (unresectabl…